期刊文献+

甲状腺功能亢进患者碘营养状态和维生素D水平评估 被引量:7

Evaluation of iodine nutrition status and vitamin D level in hyperthyroidism patients
原文传递
导出
摘要 目的 在甲状腺功能亢进症(以下简称甲亢)患者中评估碘营养状态及维生素D水平,探讨其对甲亢疾病的影响.方法 甲亢住院患者116例,测定甲状腺功能、尿碘、血清25羟维生素D [25 (OH) D]水平.以尿碘和25 (OH)D的中位数和构成比评估甲亢患者碘及维生素D的营养状态.结果 甲亢患者中尿碘中位数224.9μg/L,碘超标准摄入组占甲亢患者的59.48%(碘过量组12.93%、超足量组46.55%).25 (OH)D中位数7.19 ng/ml,维生素D缺乏占92.24%.结论 甲亢患者中需要关注碘营养状态;补充维生素D,对治疗甲亢、维护甲亢患者的骨骼、肌肉健康非常重要. Objective To evaluate iodine nutrition status and vitamin D level in hyperthyroidism patients and explore their impacts on the pathogenesis of hyperthyroidism.Methods Totally 116 inpatients of hyperthyroidism were tested for serum thyroid function,urine iodine and serum 25-OH-D.Median and component ratio of urine iodine and 25-OH-D were used to evaluate nutrition status.Results The median of urine iodine was 224.9 μg/L,while the component ratio of iodine excessive-intake was 59.48% (12.93% in excessive group and 46.55% in sufficient group).The median of vitamin D was 7.19 ng/ml while as deficiency group accounted for 93.2% in hyperthyroidism patients.Conclusions Attention should be paid to excessive intake iodine in hyperthyroidism patients.Vitamin D supplementation is important for treating hyperthyroidism and maintaining the health of skeleton and muscle.
出处 《中华临床营养杂志》 CAS CSCD 2017年第5期302-305,共4页 Chinese Journal of Clinical Nutrition
基金 新疆维吾尔自治区人民医院院内项目(201-30220)
关键词 甲状腺功能亢进症 尿碘 Hyperthyroidism Urine iodine 25 hydroxy Vitamin D
  • 相关文献

参考文献3

二级参考文献28

  • 1中华人民共和国卫生部.WS/T 107-2006尿中碘的砷铈催化分光光度法[S ].北京:人民卫生出版社,2006.
  • 2Sun X, Shah Z, Teng W. Effects of increased iodine intake on thyroid disorders [ J ]. Endocrinol Metab, 2014,29 (3) : 240-247.
  • 3Golden SH, Robinson KA, Saldanha I, et al. Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review [J]. Clin Endocrinol Metab, 2009,94(6) : 1853-1878.
  • 4Razvi S,Weaver JU,Vanderpump MP, et al. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey Cohort [ J ]. Clin Endocrinol Metab, 2010,95 (4) : 1734-1740.
  • 5Spencer CA. Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC) [J]. Clin Endocrinol Metab, 2011, 96 (12) : 3615-3627.
  • 6WHO/UNICEF/ICC/DD. Assessment of the iodine deficiency disorders and monitoring their elimination [S]. Geneva: WHO, 2001.
  • 7Delitala AP, Pilia MG, Ferreli L, et al. Prevalence of unknown thyroid disorders in a Sardinian cohort [J]. Eur J Endocrinol, 2014,171( 1 ) : 143-149.
  • 8Laurberg P, Jorgensen T, Perrild H, et al. The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives[ J]. Eur J Endocrinol,2006,155(2) :219-228.
  • 9Teng W, Shan Z, Teng X, et al. Effect of iodine intake on thyroid diseases in China[J]. N Engl J Med,2006,354(26) :2783-2793.
  • 10Diez JJ, Molina I, Ibars MT. Prevalence of thyroid dysfunction in adults over age 60 years from an urban community [J]. Exp Clin Endocfinol Diab, 2003,111 (8) : 480-485.

共引文献43

同被引文献102

引证文献7

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部